DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

35.28 -0.43 (-1.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $35.28 -1.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.20
Previous Close $35.71
Daily Range $35.05 - $36.15
52-Week Range $22.25 - $62.66
Market Cap $4.2B
P/E Ratio -44.09
Dividend (Yield) $0.00 (0.0%)
Volume 923,869
Average Daily Volume 1,493,242
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

How Big Is This Risk for Isis Pharmaceuticals, inc. Stock?

While the poor initial reception to Isis Pharmaceutical's Kynamro is upsetting, its performance might be the least of the company’s worries.

US Stock Futures Up Ahead Of Economic Data

UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT

Alnylam Pharmaceuticals Has Plenty On Its Plate

Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog

Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog

ISIS September 26th Options Begin Trading

Company News for August 05, 2014 - Corporate Summary

ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q2 2014 Results - Earnings Call Transcript

Insider Trading Alert - GPN, UHS And ISIS Traded By Insiders

Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential

See More ISIS News...

ISIS's Top Competitors

ISIS $35.28 (-1.20%)
Current stock: ISIS
AMGN $132.68 (-0.26%)
Current stock: AMGN
GILD $100.79 (-0.48%)
Current stock: GILD
BIIB $342.58 (-0.94%)
Current stock: BIIB